AIM
MDVX

Acrospire Investment Management’s Medovex Corp. Common Stock MDVX Stock Holding History

Acrospire Investment Management’s Portfolio MDVX Stock Details MDVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,683
Closed -$6K – 2676
2016
Q4 		$6K Buy
+4,683
New +$6.94K ﹤0.01% 2041

Other funds holding MDVX

MIC
Meridian Investment Counsel Lafayette, California $466M AUM 42.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FPF
FNY Partners Fund New York $185M AUM 32.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Acrospire Investment Management's MDVX Position: Q1 2017 in Review

Acrospire Investment Management sold out of Medovex Corp. Common Stock (MDVX) in Q1 2017, closing a stake of 4,683 shares — an estimated $6K sold.

Acrospire Investment Management first reported a position in MDVX in Q4 2016 and held it in 1 quarter. The position peaked at $6K in Q4 2016. 6 funds tracked by Wall St. Rank hold MDVX as of Q1 2017.

  • Acrospire Investment Management reported no remaining Medovex Corp. Common Stock position as of Q1 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 4,683 Medovex Corp. Common Stock shares in Q1 2017, an estimated $6K.
  • Acrospire Investment Management first reported a position in Medovex Corp. Common Stock in Q4 2016 and held it in 1 quarter.
  • Acrospire Investment Management's Medovex Corp. Common Stock position peaked at $6K in Q4 2016.
  • 6 funds tracked by Wall St. Rank held Medovex Corp. Common Stock as of Q1 2017.

Based on Acrospire Investment Management's 13F filing for Q1 2017, filed 4 May 2017.